Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP)

CAPS Rating: 2 out of 5

A pharmaceutical company dedicated to acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal diseases, which are those affecting the digestive tract.

Recs

1
Player Avatar Eversar (97.56) Submitted: 2/22/2010 5:02:38 PM : Outperform Start Price: $28.23 SLXP Score: +171.90

Unusually high call volume at $25, $30, & $35 for 3/10

Featured Broker Partners


Advertisement